These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1335555

  • 1. Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status.
    Ur E, Dinan TG, O'Keane V, Clare AW, McLoughlin L, Rees LH, Turner TH, Grossman A, Besser GM.
    Neuroendocrinology; 1992 Oct; 56(4):533-8. PubMed ID: 1335555
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sex differences in the ACTH response to 24H metyrapone in depression.
    Young EA, Ribeiro SC.
    Brain Res; 2006 Dec 18; 1126(1):148-55. PubMed ID: 16824495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Escape from dexamethasone-induced ACTH and cortisol suppression by corticotrophin-releasing hormone: modulatory effect of basal dexamethasone levels.
    Hermus AR, Pieters GF, Pesman GJ, Hofman J, Smals AG, Benraad TJ, Kloppenborg PW.
    Clin Endocrinol (Oxf); 1987 Jan 18; 26(1):67-74. PubMed ID: 3026693
    [Abstract] [Full Text] [Related]

  • 8. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA, Akil H, Haskett RF, Watson SJ.
    Biol Psychiatry; 1995 Mar 15; 37(6):355-63. PubMed ID: 7772643
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y, Niinomi M, Takatsuki K, Oiso Y, Tomita A.
    J Clin Endocrinol Metab; 1990 Mar 15; 70(3):798-803. PubMed ID: 2155255
    [Abstract] [Full Text] [Related]

  • 12. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
    Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER.
    J Rheumatol; 1998 Jul 15; 25(7):1374-81. PubMed ID: 9676772
    [Abstract] [Full Text] [Related]

  • 13. Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.
    Thalén BE, Kjellman BF, Ljunggren JG, Akner G, Kågedal B, Wahlund B, Wetterberg L.
    Acta Psychiatr Scand; 1993 Feb 15; 87(2):133-40. PubMed ID: 8383420
    [Abstract] [Full Text] [Related]

  • 14. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH, Siegrist J, Schuhmacher A, Hoefels S, Maier W, Zobel AW.
    Psychoneuroendocrinology; 2010 May 15; 35(4):536-43. PubMed ID: 19818562
    [Abstract] [Full Text] [Related]

  • 15. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
    Castro M, Moreira AC.
    Braz J Med Biol Res; 1990 May 15; 23(11):1107-15. PubMed ID: 1966779
    [Abstract] [Full Text] [Related]

  • 16. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A, Knyazhansky L, Loewenthal U, Arbelle J, Cohen H, Benjamin J.
    Depress Anxiety; 2005 May 15; 21(3):143-8. PubMed ID: 16001448
    [Abstract] [Full Text] [Related]

  • 17. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul 15; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 18. Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of corticotropin-releasing hormone secretion.
    Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H.
    Biol Psychiatry; 1997 Jun 15; 41(12):1149-55. PubMed ID: 9171905
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of the pituitary-adrenal system with graded doses of CRH and low dose vasopressin infusion in depressed patients and healthy subjects: a pilot study.
    Gispen-de Wied CC, Kok FW, Koppeschaar HP, Wynne HJ, Westenberg HG, Thijssen JH, van Ree JM.
    Eur Neuropsychopharmacol; 1993 Dec 15; 3(4):533-41. PubMed ID: 8111227
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.